Transcript Slide 1

An Introduction to inVentiv Health
November 2013
Who We Are
13,000 employees in 40 countries,
rapidly transforming promising
ideas into commercial reality
inVentiv Health, Inc.
is a leading global provider
of best-in-class professional
services supporting clients
in the biopharmaceutical,
medical device, and
diagnostic markets looking to
accelerate performance.
2
Why We Are Here
To respond to the evolving dynamics
in the global healthcare market
Market Opportunities
Market Challenges
 Demand for healthcare solutions is
growing (population, economic growth)
 Innovation continues to drive change
(technology)
 Increasing complexity/regulation
requires greater expertise
 Price pressure from payers
 Cost increases (R&D efficiency,
regulation)
 Requirements for differentiated/
measureable outcomes
 Patent cliff
 Large “siloed” organizations





3
…The Implications
Increasing demand for outsourced solutions
Relentless drive for efficiency/effectiveness
Increased demand for simplified engagement models—“one-stop shop”
Global, global, global
Gradual shift toward “outcomes-based” services
What We Bring
CLINICAL
World class talent and capabilities all
in ONE company
COMMERCIAL
World’s largest provider of
healthcare sales, marketing, and
communications solutions
The leading management
consulting group specializing in
pharmaceuticals and
biotechnology
 Top 5 CRO
 Outsourced sales teams and sales
 Launch planning and support
 Broad portfolio of services
support
 Marketing communications
 Advertising and public relations
 Digital communications/social media
 Corporate and business development
 Public affairs and advocacy
 Market research and analytics
 Medical education
 Organizational design and improvement
 Patient access solutions
 Pricing & market access
A leading clinical
research organization, 2012
CRO of the Year
 Deep therapeutic expertise
 Late stage/outcomes depth
 Unique capabilities in patient recruitment
 Patient outcomes, REMS, and Rx access
 Sample management and compliance
4
CONSULTING
 Corporate, product and portfolio
strategies
 Education and training
What We Do
Supporting
Outcomes-Based
Solutions Across the
Product Lifecycle
5
Help our clients to accelerate
performance, improve outcomes and
make lives better worldwide
Where We Work
AFRICA
AUSTRALIA
Cairo, Egypt
Capetown, South Africa
Johannesburg, South Africa
Auckland, New Zealand
Brisbane, Australia
Melbourne, Australia
Sydney, Australia
Wellington, New Zealand
ASIA
Bangkok, Thailand
Beijing, China
Gurgaon, India
Hong Kong, China
Hyderabad, India
Islamabad, Pakistan
Karachi, Pakistan
Kuala Lumpur, Malaysia
Lahore, Pakistan
Mumbai, India
Manila, Philippines
New Delhi, India
Pune, India
Osaka, Japan
Seoul, Korea
Shanghai, China
Singapore
Taipei, Taiwan
Tokyo, Japan
6
EUROPE
Antwerp, Belgium
Athens, Greece
Barcelona, Spain
Berlin, Germany
Bratislava, Slovakia
Bucharest, Romania
Budapest, Hungary
Cologne, Germany
Dublin, Ireland
Eltville-Martinsthal,Germany
Frankfurt, Germany
Freiburg, Germany
Istanbul, Turkey
Kyiv, Ukraine
Leusden, Netherlands
Lisbon, Portugal
London, UK
Madrid, Spain
Maidenhead, UK
Milan, Italy
Moscow, Russia
Novosibirsk, Russia
On the ground anytime, anywhere
around the world
Paris, France
Prague, Czech Republic
Ramsgate, UK
Rome, Italy
St. Petersburg, Russia
Stockholm, Sweden
The Hague, Netherlands
Vienna, Austria
Warsaw, Poland
Zug, Switzerland
Zurich, Switzerland
MIDDLE EAST
Dubai City, Dubai
Jeddah, Saudi Arabia
Ramat Gan, Israel
Riyadh, Saudi Arabia
NORTH AMERICA
Ann Arbor, MI
Augusta, GA
Blue Bell, PA
Boston, MA
Bloomington, MN
Burlington, Canada
Burlington, MA
Cary, NC
Charlotte, NC
Columbus, OH
Conshohocken, PA
Deerfield, IL
Irvine, CA
Irving, TX
Lake Mary, FL
Lexington, KY
Mexico City, Mexico
Montreal, Canada
New York, NY
Newark, DE
Newtown, PA
Overland Park, KS
Parsippany, NJ
Pointe-Claire, Canada
Princeton, NJ
Quebec City, Quebec
Raleigh, NC
Redmond, WA
San Diego, CA
San Francisco, CA
San Juan, Puerto Rico
Santa Monica, CA
Saratoga Springs, NY
Somerset, NJ
Southport, CT
Tampa, FL
The Woodlands, TX
Thousand Oaks, CA
Toronto, Canada
Washington, DC
West Chester, OH
Westerville, OH
SOUTH AMERICA
Buenos Aires, Argentina
Lima, Peru
San Isidro, Peru
Santiago de Chile, Chile
São Paulo, Brazil
How We Deliver
Strategic collaboration, shared accountability,
delivering extraordinary outcomes
Clinical
All of inVentiv’s services are customizable.
Commercial
We have the ability to combine our
best-in-class services and vast resources
Consulting
in numerous possible ways to meet
clients’ specific needs.
With this flexibility, we help our customers
solve complex challenges, deliver
extraordinary outcomes, enhance value
and improve lives.
7
Why inVentiv
One strategic partner focused on
making a difference
• Best-in-Class Capabilities • Global Scale
• World-Class Talent
• Customized Solutions
• Operational Excellence • Unique Insights & Analytics
Our Results






Top-five clinical research organization
#2 healthcare communications firm
Largest provider of outsourced healthcare sales forces in the US (second largest in Japan)
Largest recruiter of clinical and pharma sales people in world
Assisted over 2 million patients with gaining access to medication
Launched the first Facebook page for a branded drug; launched the first branded pharma
campaign on Twitter
 Has over 120 million patient prescription records (Think Analytics!)
 Worked on naming for more than one third of the approved drugs since 2008
 Generated over $1 billion of incremental revenue (for clients) in last three years through increased
compliance
8
Clinical Development Services
inVentiv Health Clinical Overview
• Industry leader
› Top 5 global CRO
› Significant global footprint - more than 6,000 employees, offices in 32
countries, operating in over 70 countries
• Diversified services across the product development continuum
› Complete product development capabilities in Phase I-Late Stage
Services
› Customized to the way you outsource: Staff Augmentation, Staffed
Groups, Functional Service Provider, Full Service Programs, and/or
Strategic Relationships
› inVentiv Commercial and Consulting expand service offering from clinical
to commercialization strategies, product branding, marketing, and sales
• Depth of therapeutic, medical, clinical, regulatory and scientific
expertise
› 168 MD and 160 PhD staff members across the organization
› Therapeutically-aligned teams
› International regulatory expertise
10
7,000 Employees operating in over 70 Countries
Dedicated to Clinical Research
inVentiv Health Clinical Network
NORTH AMERICA
EUROPE
ASIA PACIFIC
Ann Arbor, MI
Basking Ridge, NJ
Blue Bell, PA
Burlington, ON
Cary, NC
Chicago, IL
Deerfield, IL
Lake Mary, FL
Montreal, QC
New York, NY
Princeton, NJ
Quebec City, QC
San Diego, CA
Somerset, NJ
Tampa, FL
West Valley City, UT
Barcelona, ES
Berlin, DE
Bratislava, SK
Bucharest, RO
Eltville-Martinsthal, DE
Frankfurt, DE
Gravenhage, NL
Kusnacht, CH
Kyiv, UA
Leusden, NL
Madrid, ES
Maidenhead, UK
Milan, IT
Moscow, RU
Nanterre, FR
Neu-Isenburg, DE
Novosibirsk, RU
Prague, CZ
Ramsgate, UK
Rome, IT
St. Petersburg, RU
Stockholm, SE
Warsaw, PL
Auckland, NZ
Bangkok, TH
Beijing, CN
Gurgaon, IN
Hong Kong, CN
Hyderabad, IN
Kuala Lumpur, MY
Makati City, PH
Mumbai, IN
Pune, IN
Seoul, KR
Shanghai, CN
Singapore, SG
Sydney, AU
Taipei, TW
Tokyo, JP
LATIN AMERICA
Buenos Aires, AR
Lima, PE
Mexico City, MX
Santiago, CL
Sao Paulo, BR
11
FIELD-BASED
Brisbane, AU
Brussels, BE
Providencia Santiago, CL
Paris, FR
Ramat Gan, IE
Tokyo, JP
Wellington, NZ
San Isidro, PE
Johannesburg, ZA
Belgrade, Serbia
Bangkok, TH
Zagreb, HR
Sofia, BG
Budapest, HU
Copenhagen, DK
San Jose, CR
Clinical Organization
Raymond Hill
President, inVentiv Clinical
Cynthia Osborne
Executive Assistant
12
Riaz Bandali
President, Early Stage
Dawn Anderson
President, Phase II-IV
Gregg Dearhammer
President, Strategic
Resourcing
Marty Birkhofer
Chief Medical Officer
Gregory Skalicky
Exec. VP, Business
Development
Rick Shimota
Chief Financial Officer
MJ Carino
Sr. VP Human Resources
Joe Fortunato
Sr. VP, Quality Assurance
Ramita Tandon
Sr. VP & GM Patient
Outcomes
Joseph Tetzlaff
Chief Information Officer
David Peters
VP, Communications &
Corporate Development
Eric Sherbert
General Counsel
Early Stage Development
Riaz Bandali
President, Early Stage
Susanne Gosselin
Executive Assistant
George Scott
VP, Bioanalytical Services
13
Zohar Bassevitch
Sr. Director, PM & CP
Catherine Derasp
VP, Clinical Operations
Mario Tanquay
VP, Clinical
Pharmacology
Phase II-IV Development
Dawn Anderson
President, Phase II-IV
Gregory Hockel
Exec. VP, Regulatory
Affairs
Jeanne Ashton
Sr. VP, Global Data
Services
Alison O’Neill
Sue Stansfield
Exec. VP, Clinical
Operations, Phase II-IV
Sr. VP, Global Therapeutic
& Clinical Operations, NA
Jeffrey Trotter
Exec. VP, Late Stage
14
Kriszta Varga-Cox
Supervisor, Admin.
Services
Strategic Resourcing
Gregg Dearhammer
President, Strategic Resourcing
Linda Kemnitz
Executive Assistant
15
Maria Smith
Sr. Director, Grants &
Contracts
Malinda Irelan
Executive Assistant
Curt Esper
Facilities Specialist
Ann Pongracz
Director, Medical Writing
Barbara Goranson
Director, Strategic
Resourcing
Prashant Kirkire
Sr. Director, Operations
Diana Cucos
VP, Strategic Resourcing
Mark Cooper
VP, Strategic Resourcing
Marty Anderson
VP, Strategic Resourcing
Tracy Mayer
VP, Strategic Resourcing
Amy Meszaros
VP, Strategic Resourcing
Brenda Hoeper
Sr. VP, Strategic
Resourcing
Jeff Noll
Manager, Recruiting
Mishka Symonette
Exec. Director, Recruiting
Sara Gordon
VP, Communications &
Corporate Development
Brian Nelson
Director, Global
Recruitment Center
Business Development
Gregory Skalicky
Exec. VP, Business
Development
Diana Petrone
Executive Assistant
Daniel Smith
Sr. VP, Business
Development
Jason Casarella
VP, Business
Development
Fernando Martinez
Angela Russian
Exec. Director,
Business Development
VP, Business Development,
EMEA & APAC
16
Michael Ryan
VP, Business Development,
Phase II-IV
Andy Malavsky
Exec. Director, Marketing
Farah Ahmad
VP, Business
Development
Brian McAllister
Sr. Director, Business
Development
Human Resources
MJ Carino
Sr. VP, Human Resources
Jeanne Fisher
HR Associate
Rosemary McGuire
VP, Human Resources
17
Michelle Johnson
Exec. Director,
Human Resources
Donna Elbert
VP, Human Resources
Patient Outcomes
Ramita Tandon
Sr. VP & GM Patient Outcomes
Jill Guary
18
Erica Rascov
Sr. Feasibility Associate
Brent Peterson
Sr. Feasibility Associate
Halina Filipowicz
Sr. Feasibility Associate
Communication & Corporate Development
David Peters
Sr. VP, Communication &
Corporate Development
Michael McDevitt
Sr. Director, Clinical Data
Programming
Ruth Boone
Sr. Financial Analyst
Gary Leach
Financial Analyst
Alison Leaver
Sr. Data Services
Trial Leader
Nicholas Jackson
Dr. Metrics & Process
Optimization
19
General Counsel
Eric Sherbert
General Counsel
Susan Lipsitz
Assoc. General Counsel
Jesse Moore
Assoc. General Counsel
Valarie Palumbo
Sr. VP, Corporate
Quality Assurance
Charles Jewell
Assoc. General Counsel
Lisa Hieb
Assoc. General Counsel
20
Learning Development
Open Position
Learning & Development
Nancy Connell
VP, Learning & Development
21
Clinical Introduction
Phase I/Bioequivalence
Bioanalytical Services
Phase II-III
All Phases
Phase I Studies
•
•
First in Human
•
Special Populations
•
Thorough QTc
•
Drug Interactions
•
•
Generics
•
Bioavailability
•
Bioequivalence
•
High-end Generics
•
Clinical Laboratory
•
•
•
Sample Handling
Method Development and
Validation
Sample Analysis
Discovery Support
Small Molecule: LC/MS/MS
GC/MS/MS Biomarkers
Large Molecule: ELISA and RIA,
Ligand Binding Cell-based
Assays Immunogenicity Assays
Biomarkers
Capabilities
• Pharmacokinetic Analysis
• 1000+ validated assays
• Scientific Affairs and Reporting
• ~900,000 samples analyzed per
year
Capabilities
• 2 labs with over 44,000 sq ft
• 1 clinic with over 22,000 sq ft
•
22
4 clinical wards with 200 beds
Full Service
Phase IV
Strategic Resourcing
•
Biostatistics
•
Staff Augmentation
•
Product Selection
•
Clinical Development Planning
•
Staffed Groups
•
•
Data Management
•
Functional Service Provider
Risk Management and
Development
•
Medical Monitoring and
Oversight
•
Strategic Alliances
•
Pharmacoeconomics
•
Clinical Monitoring
•
•
Medical Writing
•
Medical Writing
Product Launch Support
Programs
•
Patient Recruitment
•
Pharmacovigilance
•
Pharmacovigilance
•
Project Management
•
Project Management
•
Drug-Utilization Strategies
•
Site Management
•
Clinical Staffing
•
Patient Outcome Studies
•
Study Monitoring
•
Disease Management
•
International Regulatory
Consultation/Operations
•
Brand Expansion
•
Strategies for Competitiveness
•
Medical/Scientific Consultation
Technology
•
Project Management Information System
•
Expertise with all major clinical trial databases
•
Study Supply Management
•
Investigator Database
•
Randomization
•
Electronic Trial Master File
•
Electronic Data Capture
•
Electronic Regulatory Submissions
•
PKS
•
Perceptive Informatics ‘ Initiator
Phase I and Bioequivalence Services
Accelerating Drug Development
Diverse study and
therapeutic
experience
Expedited Phase I
studies
Mitigate risk with a
professional and
skilled team
Mitigate risk with a
professional and
skilled team
23
•
15 years of Phase I drug development in a wide variety of therapeutic areas and
dosage forms
•
Conducted hundreds of studies; file more than 200 CTAs/year
•
Full suite of services ranging from protocol design to study report preparation
•
Outstanding project management skills comprised of with medical and
scientific experts to ensure volunteer safety
•
Regulatory expertise, medical writing, biostatistics, pharmacokinetics experts
•
Extensive experience working with FDA, EMA, Heath Canada, and Europeanbased agencies
•
Rapid recruitment
•
Streamlined study execution
•
State of the art data management technologies ensure fast, accurate
reporting for real time decision making
•
22,000 square foot clinical facility with 200 beds divided into 4 units
•
Clinical lab, on-site pharmacy
•
Partnerships with local hospitals
Bioanalytical Services: Market-leading Small,
Large Molecule Scientific Expertise
This is how inVentiv Health Clinical transforms promising ideas
into commercial reality:
Scientific Expertise
Rapid Analysis and
Large Capacity of
Small Molecule
Expertise in Large
Molecules
Risk Management
through quality
and compliance
24
•
18+ years of experience in method development, validation and analysis
•
Over 1000 assays and biomarkers methods available
•
Two GLP facilities with state-of-the art instrumentation
•
One of the largest capacities of any bioanalytical lab
•
Largest suite of mass specs in the industry
•
Rapid turnaround times
•
Scientific expertise in a wide variety of large molecule projects
•
Scientific leadership to address more complex projects including novel
compounds
•
High capacity
•
Project Management
•
Robust Sample management process
•
Outstanding quality and compliance and regulatory expertise
Integrated, Full-Service Phase II-III Product
Development Expertise
Comprehensive
Development
Services
Mitigate Risk with a
Professional and
Skilled Team
Specialization in
Therapeutic Areas
Rapid Patient
Recruitment
• Biostatistics, Data Management and Statistical Programming
• Clinical Monitoring, Project Management and Strategic Oversight
• Patient and investigator recruitment
• Clinical development planning and expert project management
• International regulatory consulting
• Medical/scientific
• Therapeutically aligned leadership with strong product development
experience and background
• Integrated teams deliver technical, operational and therapeutic expertise
for lifecycle management
• Trial feasibility and site selection, site approvals
• Patient recruiting strategy
• Access to claims data of 90 million patients in the US
25
Specialization in Core Therapeutic Areas
• Therapeutically aligned
leadership with strong
product development
experience and background
• Fully integrated teams to
deliver technical, operational
and therapeutic expertise
• Therapeutically aligned site
selection and patient
recruitment expertise
• Other specialty areas:
› Pediatrics >80 Studies
› Phase IV >195 Studies
26
Therapeutic Area of Focus
Trials
Hematology and Oncology
>370
Neuroscience
>430
General Medicine
>300
Infectious Disease
>260
Cardiology, Endocrinology, Metabolic disease
>230
Pain and Inflammatory Disease
>150
Phase IV Services: Bridging the Gap Between
Development and Commercialization
Comprehensive
Phase IV Services
Real world
experience, real
value
27
•
•
•
•
Observational/non-interventional • Post-approval safety surveillance
Retrospective research
• Epidemiology
Label extension trials
• Patient-reported outcomes
Expanded access studies
• Pragmatic, scientifically sound, trial design and operational
cost-efficiency
Proactive
Recruitment
• inVentiv Physician Network provides access to investigators
dedicated to observational and non-interventional research and
patients
Part of the Expert
inVentiv network
• Part of expert inVentiv network dedicated to safe and effective
commercialization, including ParagonRx (REMS) and Campbell
Alliance (consulting, CER)
Custom Resourcing Solutions
Flexible/Scalable
Resourcing
• More than 3,000 people working in 30 countries
• Combines strength of FSP with industry leading staffing capabilities
• Worked with over 160 companies-suite of services ranging from staff
augmentation to strategic partnerships
•
Experienced FSP
Partner
46 active FSPs, 25 clients including Top 5 and 10 Pharma
• Dedicated teams in all functions/phases can achieve up to
30% savings
• Staff lift outs/asset transfer can yield huge savings for clients
•
•
Worldwide
Staffing
Resources
•
•
•
28
12 managed staffing relationships, 9 unique clients
40+ years combined experience in US, EU, Asia and Latin America
Contract or permanent staffing, internal teams, FSPs
Database of ~200,000 candidates worldwide with broad therapeutic
and functional expertise
Industry-leading retention rates
Therapeutically-aligned Expertise
Developed over 12 years
Dedicated staff for each division
Physicians within TA
Senior leaders (20+ years)
Project managers (10+ years)
CRA alignment
All geographic regions
Hematology &
Oncology
Neuroscience
Pain Cardiovascular Inflammation
Metabolic
29
Vaccines/ ID &
Respiratory
Resources become
experts within a core
therapeutic area
General
Medicine
Operational efficiency
Scientific quality
Site, KOLs, and regulatory relationships
Engaged and informed management
Therapeutically-aligned Expertise
Oncology
Unique inVentiv advantages
› The Navicor Group, an InVentiv Company
› Dedicated Phase 1 team
› Substantial specialization in breast cancer
Oncology
Trials
› 381 last 5 years (all services)
› 251 Clinical
› > 8,900 sites
› > 61,000 patients
Solid tumors
30
Hematologic
›
156 last 5 years›
›
8,700 sites
›
66,000 patients ›
›
95 last 5 years
4,065 sites
30,750 patients
› Expertise in rare hematologic malignancies
› 11 recent NDA/sNDA approvals
Therapeutically-aligned Expertise
Neuroscience
Unique inVentiv advantages
› Partnership for Phase 1 disease state
› Integrated Rater Training services
› Scale licensing and translation
Neuroscience
Trials
› 345 last 5 years (all
services)
› 146 Clinical
› > 5,900 sites
› > 44,300 patients
31
› Staff have served as PI, site coordinators
(especially AD)
› Psychologists on team (including
neuropsychologists)
› 8 recent NDA/sNDA approvals
Therapeutically-aligned Expertise
Pain and Inflammation
Unique inVentiv advantages
› More than 50 RA/OA trials
› Post-surgical experience
› Drug - Device combinations
Pain and
Inflammation
› Manage scheduled substances
Trials
› 153 trials last 5 years (all services)
› 106 clinical
› > 6,800 Sites
› > 39,400 Patients
32
Therapeutically-aligned Expertise
Cardiovascular and Metabolism
Unique inVentiv advantages
› Imaging including IVUS
› Hospital based-studies
› Endpoint management
Cardiovascular and
Metabolism
› Pediatric and adolescent CV/Metabolism
Trials
› 247 last 5 years (all services)
› 123 Clinical
› > 7,300 Sites
› > 67,300 Patients
33
Therapeutically-aligned Expertise
Vaccines and Infectious Disease
Unique inVentiv advantages
› Cold chain process
› Bio-terrorism research
› Government funded (DoD, HHS, BARDA)
ID/Vaccine and
Respiratory
› Vaccine network
› Site capacity building/TB
› Strategic partnership experience
ID/ Vaccine Trials
› 186 last 5 years (all
services)
› 87 Clinical
› > 3,200 Sites
› > 60,300 Patients
34
Therapeutically-aligned Expertise
General Medicine
General
Medicine
Dermatology
Gastroenterology
Nephrology/Urology
Ophthalmology
Rare Diseases
Transplant
Women’s Health
Unique inVentiv advantages
Trials
› 260 last 5 years (all services)
› 140 Clinical
› Dialysis site networks
› Home health network
› > 6,000 Sites
› Hospital-based study experience
› > 62,500 Patients
› Stem cell research
› Significant orphan drug/rare disease
experience
35
Therapeutically-aligned Expertise
Pediatrics
Cardiovascular
Dermatology
Endocrinology & Metabolism
Gastroenterology
Hematology & Oncology
Infectious Disease/Vaccines
Neuroscience
Rare Diseases
Respiratory
Pediatrics
Unique inVentiv advantages
Trials
› 110 last 5 years
(all services)
› 72 Clinical
› Consulting of the European Pediatric
legislation and the US FDA PREA and
BPCA Acts
› > 2,400 Sites
› Pediatric Investigational Plans (PIPs)
› > 34,200 Patients
› Experience with pediatric investigators
› Pediatric Informed Consent
› Consulting on age appropriate formulations
and toxicity testing
36
Feasibility and
Patient Recruitment/Retention
World class, comprehensive services
Investigator and Patient Strategies
• inVentiv Clinical’s protocol feasibility, site selection and patient
recruitment strategies are driven by data and analytics
• Ensures an effective and efficient approach to securing and
retaining both investigators and patients
38
Investigator and Patient Strategies
• Our extensive experience managing and conducting global
assessments includes:
› Greater than 1,100 total patient recruitment and retention projects
spanning 170+ indications
› >90 countries globally, >200 feasibility and site identification programs
annually
› Aggregated wealth of historical performance data and investigatorreported information to build a data asset that can better prioritize
investigator sites
› Run algorithms against the data to identify the right number of the most
effective investigators
› Increases the number of high-performing sites to meet trial timelines
• Best practices approach involves thorough analysis of the study
design as well as ideal patient and investigator profiles
39
Data Driven Analysis and Planning
• We maintain exclusive access to United Health Group integrated
claims database reports
› Captures140 million covered lives inclusive of Commercial, Medicare
and Medicaid populations
› Longitudinal dataset is mined using ICD-9, CPT, NDC codes and FDA
BMIS records
• Specific to indication and protocol criteria, information related to
physician treatment patterns, research experience, and patient
health care are assessed
› Key applications
• Identifies ideal physician profiles (location, name, practice, etc) who is treating, to what degree they treat, research experience,
specialty
• Gives broader community and referring physician pool
• Data findings are then applied/extrapolated globally
40
Data Driven Analysis and Planning
• Adheris, an inVentiv Health company, database contains rich and
real- time prescription data for more than 120 million patients
› Largest, direct-to-patient (DTP) database for HIPAA compliant, clinical
trial patient recruitment
› Provides proprietary access to patient and prescription level, plus
disease and physician profile data including the following:
• Patient demographics
• Product daily dose, formulation and strength
• Six years of treatment history
• Physician demographics, practice characteristics
› Identify prospective clinical trial candidates in a faster, more effective
DTP manner for efficient outreach
41
Our Step-by-Step Approach to
Designing the Plan
OUR APPROACH
All our programs are based
on a detailed assessment of
the challenges to deliver
only the most-effective,
evidence-based solutions.
42
1.
Understand the recruitment and
environmental challenges
2.
Identify and understand our
stakeholders and their drivers for
participation
3.
Understand how, when and where to
engage/integrate with patients, HCPs
and other stakeholders
4.
Create a powerful visual identity that
resonates across all stakeholders
5.
Target the right messages to the right
stakeholders at the right time;
measure and analyze
One strategic partner supporting
clients through every phase of the
product life cycle
Why inVentiv Health?
• Best-in-Class Capabilities
•
– Innovative solutions based upon industrywide experience
•
Global Scale
– Seamless ability to scale up or down
as needed
•
– Operations in more than 40 countries
•
World-Class Talent
– 13,000 employees across three business
segments
•
Operational Excellence
– Ability to make decisions and deploy
resources rapidly
43
Customized Solutions
Rigorous Analytics
– Proven methodologies applied across
the lifecycle
•
Unique Insights
– Strategic lens applied to tactical
know-how